Matthew Parris
Chief Tech/Sci/R&D Officer at TRAWS PHARMA, INC.
Matthew Parris active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TRAWS PHARMA, INC. | Chief Tech/Sci/R&D Officer | 2018-07-31 | - |
Career history of Matthew Parris
Former positions of Matthew Parris
| Companies | Position | Start | End |
|---|---|---|---|
Eleison Pharmaceuticals, Inc.
 Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | - | - |
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
| INOVIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Training of Matthew Parris
| Imperial College London | Undergraduate Degree |
Statistics
International
| United States | 5 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Matthew Parris
- Experience
